These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3110069)

  • 1. Immunosuppressive effect of cyclosporin A on Mycobacterium bovis BCG infections in mice.
    Takashima T; Collins FM
    Infect Immun; 1987 Jul; 55(7):1701-6. PubMed ID: 3110069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preexisting inflammation due to Mycobacterium bovis BCG infection differentially modulates T-cell priming against a replicating or nonreplicating immunogen.
    Dudani R; Chapdelaine Y; van Faassen H; Smith DK; Shen H; Krishnan L; Sad S
    Infect Immun; 2002 Apr; 70(4):1957-64. PubMed ID: 11895959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention by gamma interferon of fatal infection with Listeria monocytogenes in mice treated with cyclosporin A.
    Nakane A; Minagawa T; Yasuda I; Yu C; Kato K
    Infect Immun; 1988 Aug; 56(8):2011-5. PubMed ID: 3135267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
    Ladel CH; Daugelat S; Kaufmann SH
    Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.
    Heldwein KA; Liang MD; Andresen TK; Thomas KE; Marty AM; Cuesta N; Vogel SN; Fenton MJ
    J Leukoc Biol; 2003 Aug; 74(2):277-86. PubMed ID: 12885945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.
    Bourassa D; Forget A; Pelletier M; Skamene E; Turcotte R
    Clin Exp Immunol; 1985 Oct; 62(1):31-8. PubMed ID: 3905097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequencies of IFN gamma- and IL-4-producing cells during Mycobacterium bovis BCG infection in two genetically susceptible mouse strains: role of alpha/beta T cells and NK1.1 cells.
    Teixeira HC; Munk ME; Kaufmann SH
    Immunol Lett; 1995 May; 46(1-2):15-9. PubMed ID: 7590911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice.
    Kawamura I; Tsukada H; Yoshikawa H; Fujita M; Nomoto K; Mitsuyama M
    J Immunol; 1992 May; 148(9):2887-93. PubMed ID: 1374103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An essential role for endogenous interferon-gamma in the generation of protective T cells against Mycobacterium bovis BCG in mice.
    Yang J; Mitsuyama M
    Immunology; 1997 Aug; 91(4):529-35. PubMed ID: 9378490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG.
    Kawahara M; Hasegawa N; Takaku H
    PLoS One; 2016; 11(3):e0152051. PubMed ID: 26999357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice.
    Cox JH; Knight BC; Ivanyi J
    Infect Immun; 1989 Jun; 57(6):1719-24. PubMed ID: 2656521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
    Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
    Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
    Kramnik I; Radzioch D; Skamene E
    Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of white-tailed deer (Odocoileus virginianus) to Mycobacterium bovis BCG vaccination.
    Waters WR; Palmer MV; Whipple DL; Slaughter RE; Jones SL
    J Wildl Dis; 2004 Jan; 40(1):66-78. PubMed ID: 15137490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporin A on immunity to Listeria monocytogenes.
    Hügin AW; Cerny A; Wrann M; Hengartner H; Zinkernagel RM
    Infect Immun; 1986 Apr; 52(1):12-7. PubMed ID: 3485573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of DNA- and Mycobacterium bovis BCG-based delivery of the Flt3 ligand on protective immunity to Mycobacterium tuberculosis.
    Triccas JA; Shklovskaya E; Spratt J; Ryan AA; Palendira U; Fazekas de St Groth B; Britton WJ
    Infect Immun; 2007 Nov; 75(11):5368-75. PubMed ID: 17724075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
    Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
    J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells induce CD4+ and CD8+ T-cell responses to Mycobacterium bovis and M. avium antigens in Bacille Calmette Guérin vaccinated and nonvaccinated cattle.
    Hope JC; Kwong LS; Sopp P; Collins RA; Howard CJ
    Scand J Immunol; 2000 Sep; 52(3):285-91. PubMed ID: 10972905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice.
    Brandely M; Lagrange PH; Hurtrel B
    Clin Exp Immunol; 1986 Jan; 63(1):118-26. PubMed ID: 3514011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycobacterium bovis BCG-infected mice are more susceptible to staphylococcal enterotoxin B-mediated toxic shock than uninfected mice despite reduced in vitro splenocyte responses to superantigens.
    Pedras-Vasconcelos JA; Chapdelaine Y; Dudani R; van Faassen H; Smith DK; Sad S
    Infect Immun; 2002 Aug; 70(8):4148-57. PubMed ID: 12117923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.